TrialThe Lancet. Infectious diseases2017

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.

Michelle J Groome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.